Two years later, the same authors put forward that sv-cystatin was also able to suppress tumor angiogenesis by reducing the level of vascular endothelial growth factor (VEGF)-A165, basic fibroblast growth factor (bFGF), and fms-related tyrosine kinase 1 (Flt-1) [18]. Here, FGF2 is linked to neoplasm.